EFFECTS OF INHALED NITRIC-OXIDE IN RATS WITH CHEMICALLY-INDUCED PULMONARY-HYPERTENSION

被引:11
作者
KATAYAMA, Y
HATANAKA, K
HAYASHI, T
ONODA, K
YADA, I
NAMIKAWA, S
YUASA, H
KUSAGAWA, M
MARUYAMA, K
KITABATAKE, M
机构
[1] MIE UNIV, SCH MED, DEPT ANAESTHESIOL, TSU, MIE 514, JAPAN
[2] MIE UNIV, SCH MED, DEPT THORAC & CARDIOVASC SURG, TSU, MIE 514, JAPAN
[3] MIE UNIV, SCH MED, DEPT PUBL HLTH, TSU, MIE 514, JAPAN
来源
RESPIRATION PHYSIOLOGY | 1994年 / 97卷 / 03期
关键词
HYPERTENSION; PULMONARY; MONOCROTALINE; NO; MAMMALS; RAT; MEDIATORS; VASOACTIVE SUBSTANCES;
D O I
10.1016/0034-5687(94)90066-3
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To determine the model animal with pulmonary hypertension in which nitric oxide (NO) inhalation reduces pulmonary arterial pressure (PAP), we examined the inhalation of 20-100 ppm NO gas on normal rats and rats with monocrotaline induced pulmonary hypertension. In the control group, mean PAP showed no change after spontaneous breathing of NO at the concentration of 20 to 100 ppm for 5 min. On the contrary, in both the severe (mean PAP>40 mmHg) and moderate (mean PAP<40 mmHg) pulmonary hypertensive groups, NO inhalation produced a prompt reduction of the mean PAP which had been elevated by monocrotaline. 20 ppm NO inhalation reduced mean PAP from 64.4 +/- 3.7 mmHg to 56.2 +/- 4.4 mmHg (mean +/- SEM, P<0.01) in the severe pulmonary hypertensive group, from 31.0 +/- 2.0 mmHg to 24.2 +/- 0.9 mmHg in the moderate pulmonary hypertensive group (mean +/- SEM, P<0.05). The onset of the reduction of mean PAP occurred within 30 sec after the start of NO inhalation and maximum reduction occurred within 4 min. 20 ppm NO inhalation significantly reduced mean PAP, and mean PAP was reduced dose-dependently at the concentration of 20 to 60 ppm and reaction to NO was almost constant at the concentrations of over 60 ppm.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 18 条
[1]  
ALTIERE RJ, 1986, J PHARMACOL EXP THER, V236, P390
[2]   INHALED NITRIC-OXIDE - A SELECTIVE PULMONARY VASODILATOR REVERSING HYPOXIC PULMONARY VASOCONSTRICTION [J].
FROSTELL, C ;
FRATACCI, MD ;
WAIN, JC ;
JONES, R ;
ZAPOL, WM .
CIRCULATION, 1991, 83 (06) :2038-2047
[3]   CHANGES IN PULMONARY STRUCTURE AND FUNCTION INDUCED BY MONOCROTALINE INTOXICATION [J].
GHODSI, F ;
WILL, JA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1981, 240 (02) :H149-H155
[4]   INHALED NITRIC-OXIDE AFTER MITRAL-VALVE REPLACEMENT IN PATIENTS WITH CHRONIC PULMONARY-ARTERY HYPERTENSION [J].
GIRARD, C ;
LEHOT, JJ ;
PANNETIER, JC ;
FILLEY, S ;
FFRENCH, P ;
ESTANOVE, S .
ANESTHESIOLOGY, 1992, 77 (05) :880-883
[5]  
HAYASHI Y, 1966, FED PROC, V25, P688
[6]  
HERGET J, 1972, ARCH INT PHARMACOD T, V198, P107
[7]  
IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893
[9]   ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE [J].
IGNARRO, LJ ;
BUGA, GM ;
WOOD, KS ;
BYRNS, RE ;
CHAUDHURI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9265-9269
[10]   LOW-DOSE INHALATIONAL NITRIC-OXIDE IN PERSISTENT PULMONARY-HYPERTENSION OF THE NEWBORN [J].
KINSELLA, JP ;
NEISH, SR ;
SHAFFER, E ;
ABMAN, SH .
LANCET, 1992, 340 (8823) :819-820